^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
SeekInCare™

Company:
SeekIn
Type:
CE Marked
Related tests:

Details

Evidence
With the mission to detect cancer when it is still curable, SeekInCare® has been developed as a pan cancer detection test that takes a panoramic view of blood cell-free cancer signatures and a multi-omics approach incorporating genomic and epigenetic alterations in conjunction with clinically validated protein biomarkers. Equipped with proprietary AI- and big data-driven CRS algorithm, SeekInCare exhibits superior effectiveness to detect dozens of cancer types at high specificity.
Method:
Liquid biopsy
Approvals
Date
Cancer
Gene
Drug
By
02/24/22
CE